Spontaneous bioelectrical activity of the brain and the duration of gasping were recorded in mice during modeling of global strangulation ischemia of the brain against the background of preventive administration of citicoline. The maximum neuroprotective effect of citicoline was observed when it was administered 60 min before the simulation of ischemia and was completely prevented by preliminary administration of a selective P2Y6 receptor antagonist MRS2578. The obtained experimental data attest to the leading role of receptor mechanisms in the implementation of neuroprotective activity of citicoline.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Khushdil A, Ahmed Z, Ehsan A. Role of citicoline in treatment of moderate to severe birth asphyxia: a pilot project. J. Coll. Physicians Surg. Pak. 2021;31(12):1511-1512. doi: https://doi.org/10.29271/jcpsp.2021.12.1511
Secades JJ. Citicoline: pharmacological and clinical review, 2016 update. Rev. Neurol. 2016;63(Suppl. 03):S1-S73.
Secades JJ. Role of citicoline in the management of traumatic brain injury. Pharmaceuticals (Basel). 2021;14(5):410. doi: https://doi.org/10.3390/ph14050410
Sufianova GZ, Sufianov AA, Shapkin AG, Khlestkina MS, Mashkin AM, Sufianov RA. Preventive citicoline administration is more effective than therapeutic in model of transient cerebral ischemia in rats. Sechenov. Vestn. 2019;10(2):21-28. Russian. doi: https://doi.org/10.26442/22187332.2019.2.21-28
Ebrahimi S, Ashkani Esfahani S, Ebrahimi A. Comparison of the effects of citicoline and piracetam on hypoxic-ischemic brain damage in neonatal rabbits. Iran. J. Child Neurol. 2022;16(1):77-84. doi: https://doi.org/10.22037/ijcn.v15i4.29816
Grieb P. Neuroprotective properties of citicoline: facts, doubts and unresolved issues. CNS Drugs. 2014;28(3):185-193. doi: https://doi.org/10.1007/s40263-014-0144-8
Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res. Rev. 2006;52(2):389-397. doi: https://doi.org/10.1016/j.brainresrev.2006.05.001
Löffler M, Carrey EA, Zameitat E. New perspectives on the roles of pyrimidines in the central nervous system. Nucleosides Nucleotides Nucleic Acids. 2018;37(5):290-306. doi: https://doi.org/10.1080/15257770.2018.1453076
Neher JJ, Neniskyte U, Hornik T, Brown GC. Inhibition of UDP/P2Y6 purinergic signaling prevents phagocytosis of viable neurons by activated microglia in vitro and in vivo. Glia. 2014;62(9):1463-1475. doi: https://doi.org/10.1002/glia.22693
Wen RX, Shen H, Huang SX, Wang LP, Li ZW, Peng P, Mamtilahun M, Tang YH, Shen FX, Tian HL, Yang GY, Zhang ZJ. P2Y6 receptor inhibition aggravates ischemic brain injury by reducing microglial phagocytosis. CNS Neurosci. Ther. 2020;26(4):416-429. doi: https://doi.org/10.1111/cns.13296
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 1, pp. 55-58, January, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sufianova, G.Z., Shapkin, A.G., Khlestkina, M.S. et al. The Role of P2Y6 Receptors in the Mechanisms of the Neuroprotective Effect of Citicoline. Bull Exp Biol Med 175, 45–48 (2023). https://doi.org/10.1007/s10517-023-05808-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05808-z